Cite
HARVARD Citation
Franceschi, E. et al. (n.d.). 2924 Time to response (TTR) and early tumor shrinkage (ETS) in recurrent glioblastoma patients treated with bevacizumab: An exploratory analysis of the prospective randomized AVAREG (ML25739) phase II study. European journal of cancer. pp. S592-. [Online].